An experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma helps three out of four patients for complete remission following the treatment. Fred Hutch immunotherapy researcher Dr. Kelly Paulson used a combination of T-cell therapy, immunotherapy drug and radiation and tested its effect on patients with Merkel cell carcinoma.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer